Rituximab in the Management of Refractory Myasthenia Gravis and Variability of Its Efficacy in Anti-MuSK Positive and Anti-AChR Positive Myasthenia Gravis

Myasthenia gravis affects the neuromuscular junction of the skeletal muscles. It results in muscle weakness involving skeletal muscles (diaphragm, extraocular muscles) and myasthenic crisis. Treatment options for myasthenia gravis management have expanded, including azathioprine, corticosteroids, pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Bastakoti, Sanjiv, Kunwar, Saru, Poudel, Sujan, Quinonez, Jonathan, Bista, Seema, Singh, Navpreet, Jha, Vivek, Ruxmohan, Samir, Paesani, Sylvia, Cueva, Wilson, Michel, Jack
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660595/
https://www.ncbi.nlm.nih.gov/pubmed/34909332
http://dx.doi.org/10.7759/cureus.19416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660595/
https://www.ncbi.nlm.nih.gov/pubmed/34909332
http://dx.doi.org/10.7759/cureus.19416

Ejemplares similares